Bausch Health Companies (BHC) Capital Expenditures (2009 - 2026)
Bausch Health Companies (BHC) posted Capital Expenditures of $77.0 million for Q2 2026, down 29.36% sequentially from $109.0 million in Q1 2026, and down 22.22% YoY from $99.0 million in Q2 2025.
Bausch Health Companies (BHC) Capital Expenditures (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Capital Expenditures for 18 years, with the latest figure at $77.0 million in Q2 2026.
- Quarterly Capital Expenditures fell 22.22% year-over-year to $77.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $369.0 million (down 5.63% YoY) and the FY2025 annual result came in at $397.0 million, up 17.8% from the prior year.
- Capital Expenditures eased to $77.0 million in Q2 2026 per BHC's latest filing, from $109.0 million in the prior quarter.
- Over five years, Capital Expenditures peaked at $115.0 million in Q1 2025 and troughed at $28.0 million in Q2 2023.
- A 5-year average of $75.2 million and a median of $77.5 million in 2024 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2023 and 2024: Capital Expenditures slumped 46.15% in 2023, then jumped 178.57% in 2024.
- Over 5 years, Capital Expenditures stood at $66.0 million in 2022, then soared by 48.48% to $98.0 million in 2023, then advanced by 8.16% to $106.0 million in 2024, then dropped by 13.21% to $92.0 million in 2025, then slipped by 16.3% to $77.0 million in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $77.0 million, $109.0 million, and $92.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Bausch Health Companies | 2.57 Bn | 732.63 Mn | 2.10 Bn | 77.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 77.00 Mn |
| Jun 30, 2026 | 77.00 Mn |
| Mar 31, 2026 | 109.00 Mn |
| Mar 31, 2026 | 109.00 Mn |
| Dec 31, 2025 | 92.00 Mn |
| Dec 31, 2025 | 92.00 Mn |
| Sep 30, 2025 | 91.00 Mn |
| Sep 30, 2025 | 91.00 Mn |
| Jun 30, 2025 | 99.00 Mn |
| Jun 30, 2025 | 99.00 Mn |
| Mar 31, 2025 | 115.00 Mn |
| Mar 31, 2025 | 115.00 Mn |
| Dec 31, 2024 | 106.00 Mn |
| Dec 31, 2024 | 106.00 Mn |
| Sep 30, 2024 | 71.00 Mn |
| Sep 30, 2024 | 71.00 Mn |
| Jun 30, 2024 | 78.00 Mn |
| Jun 30, 2024 | 78.00 Mn |
| Mar 31, 2024 | 82.00 Mn |
| Mar 31, 2024 | 82.00 Mn |